Codexis, Inc.

NasdaqGS:CDXS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 229.48 M

Share Price

USD 2.77

Avg Daily Volume

909,285

Change (1 day)

-0.36%

Change (1 year)

-12.06%

Change (YTD)

-41.93%

Codexis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -130.07%

Codexis, Inc. EBITDA Margin is -130.07% for the Trailing 12 Months (TTM) ending March 31, 2025, a 184.37% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Codexis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -45.74%, a 41.46% change year over year.
Codexis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -32.33%, a 156.27% change year over year.
Codexis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -12.62%, a -55.44% change year over year.
Codexis, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -28.32%, a 81.65% change year over year.